✦ LIBER ✦

Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) inEscherichia coli

✍ Scribed by Akbari, Vajihe; Mir Mohammad Sadeghi, Hamid; Jafrian-Dehkordi, Abbas; Abedi, Daryoush; Chou, C. Perry

Book ID: 121819410
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 775 KB
Volume: 41
Category: Article
ISSN: 1476-5535
DOI: 10.1007/s10295-014-1437-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cloning, expression and purification of

Cloning, expression and purification of a single chain variable fragment antibody against Her2 in Escherichia coli

✍ Akbari, Vajihe; Abedi, Daryoush; Sadeghi, Hamid Mir Mohammad; Jafrian-Dehkordi, 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 59 KB

Bioscreening of phage display antibody l

Bioscreening of phage display antibody library and expression of a humanized single-chain variable fragment antibody against human connective tissue growth factor (CTGF/CCN2)

✍ Guoqiu Wu; Xiaobo Fan; Hongbin Wu; Naifeng Liu; Xiaofang Li; Lixia Gou; Yu Nie; 📂 Article 📅 2010 🏛 Portland Press 🌐 English ⚖ 221 KB

Autocrine Inhibition of the Epidermal Gr

Autocrine Inhibition of the Epidermal Growth Factor Receptor by Intracellular Expression of a Single-Chain Antibody

✍ R.R. Beerli; W. Wels; N.E. Hynes 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 410 KB

Functional expression of a single-chain

Functional expression of a single-chain antibody specific for the HER2 human oncogene in a bacterial reducing environment

✍ Alessio Lombardi; Maria Sperandei; Cristina Cantale; Patrizio Giacomini; Patrizi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Cloning, expression, purification, and c

Cloning, expression, purification, and characterization of a novel single-chain variable fragment antibody against the 2-nitrobenzaldehyde derivative of a furaltadone metabolite in Escherichia coli

✍ Wuying Yang; Hong Wang; Jiexian Dong; Zhenlin Xu; Yudong Shen; Yuanming Sun; Xix 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Phase II Study of the Antibody Drug Conj

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy

✍ Burris, H. A.; Rugo, H. S.; Vukelja, S. J.; Vogel, C. L.; Borson, R. A.; Limenta 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB